Colorado Blood Cancer Institute Team of Specialists
Dr. Mark W. Brunvand, Dr. Jeffery V. Matous, Dr. Michael B. Maris, Dr. Tara K. Gregory,
Dr. Richard A. Nash, Dr. Peter A. McSweeney, Dr. Scott I. Bearman
The Colorado Blood Cancer Institute is advancing care for patients with blood and marrow disorders, as well as specific cancers through compassionate treatment, education and research. Our transplant program, performs over 200 transplants annually serving patients from Nebraska, Wyoming, Kansas, Utah, Montana, Arizona and Colorado. Very few transplant programs in the country can offer the level of experience and expertise provided by the physicians and staff at CBCI.
The Program is a National Marrow Donor Program (NMDP) apheresis, collection and transplant facility in, as well as a FACT-accredited program performing autologous, related donor and unrelated donor transplants and cord blood transplants.
CBCI’s research efforts are driven from a desire to broaden the scope of eligible stem cell transplant recipients. Through the use of non-myeloablative or reduced intensity allogeneic transplants and cord blood transplants, we are able to broaden both the age and ethnicity of our potential patient population.
Our transplant team includes program psychologists, social workers, dietitians, mid-level practitioners, medical assistants, financial and transplant nurse coordinators, and oncology certified registered nurses. Our Long Term Follow Up Program manages the possible complications of our allogeneic patient's Graft Versus Host Disease (GVHD). We not only follow the patient but are also a resource for our referring physicians whose patient's have returned to their care.
The program's volume has grown steadily over the past 19 years. In February of 2011, we will perform our 2000th transplant. Current annual volumes exceed 200 stem cell and bone marrow transplants. While our facilities are in the heart of Denver, Colorado our patients come from Nebraska, Wyoming, Kansas, Utah, Montana, Arizona and Western Colorado.